Moreover, CC16 mRNA levels appeared to be dramatically reduced in the lungs of COVID-19 patients, and the circulating CC16 levels in serum were significantly decreased in COVID-19 patients compared to the healthy controls [75]. The gene discussed is SCGB1A1; the disease is COVID-19.